Clinical trial
A Phase IV Study to Evaluate the SUBLOCADE Treatment Exit Strategy
NCT05878210 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV Study to Evaluate the SUBLOCADE Treatment Exit Strategy
- Lead sponsor
- Indivior Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 24, 2023
- Completion date
- May 9, 2025
- Enrollment
- 12 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
opioid use disorder